Real question is why the company keeps the trial extended into another year. You can have a million of excuses but obvious one is that data is not impressive, or not convinced. Dr. M is very smart to release all fluff news to keep stock price floating. Another question is why company withdrew the submitted abstract for 15 month data. Could be another red flag. Eventually, all things will prove that AF is right.
Market Data 
Markets 
AI
